This evidence prompted us to investigate specific loci encompassing p53 and p73 genes by microsatellite analysis using the fluorescent multiplex PCR technique, and to investigate genetic markers that could help predict the clinical outcome of chemoradiotherapy in bladder cancer. This evidence concerns the gene TP53 and urinary bladder cancer.